1. NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease.
- Author
-
Triaca V, Sposato V, Bolasco G, Ciotti MT, Pelicci P, Bruni AC, Cupidi C, Maletta R, Feligioni M, Nisticò R, Canu N, and Calissano P
- Subjects
- Adult, Amyloid Precursor Protein Secretases metabolism, Animals, Aspartic Acid Endopeptidases metabolism, Enzyme Activation drug effects, Gene Deletion, Golgi Apparatus drug effects, Golgi Apparatus metabolism, Hippocampus pathology, Humans, JNK Mitogen-Activated Protein Kinases metabolism, Male, Mice, Inbred C57BL, Neurons drug effects, Neurons metabolism, PC12 Cells, Phosphorylation drug effects, Protein Binding drug effects, Rats, Receptor, trkA metabolism, Src Homology 2 Domain-Containing, Transforming Protein 3 metabolism, Alzheimer Disease metabolism, Alzheimer Disease pathology, Amyloid beta-Protein Precursor metabolism, Down-Regulation drug effects, Nerve Growth Factor pharmacology, Phosphothreonine metabolism
- Abstract
NGF has been implicated in forebrain neuroprotection from amyloidogenesis and Alzheimer's disease (AD). However, the underlying molecular mechanisms are still poorly understood. Here, we investigated the role of NGF signalling in the metabolism of amyloid precursor protein (APP) in forebrain neurons using primary cultures of septal neurons and acute septo-hippocampal brain slices. In this study, we show that NGF controls the basal level of APP phosphorylation at Thr668 (T668) by downregulating the activity of the Ser/Thr kinase JNK(p54) through the Tyr kinase signalling adaptor SH2-containing sequence C (ShcC). We also found that the specific NGF receptor, Tyr kinase A (TrkA), which is known to bind to APP, fails to interact with the fraction of APP molecules phosphorylated at T668 (APP(pT668) ). Accordingly, the amount of TrkA bound to APP is significantly reduced in the hippocampus of ShcC KO mice and of patients with AD in which elevated APP(pT668) levels are detected. NGF promotes TrkA binding to APP and APP trafficking to the Golgi, where APP-BACE interaction is hindered, finally resulting in reduced generation of sAPPβ, CTFβ and amyloid-beta (1-42). These results demonstrate that NGF signalling directly controls basal APP phosphorylation, subcellular localization and BACE cleavage, and pave the way for novel approaches specifically targeting ShcC signalling and/or the APP-TrkA interaction in AD therapy., (© 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF